Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Martin Herber"'
Autor:
Marc-Oliver Grimm, Viktor Grünwald, Harald Müller-Huesmann, Philipp Ivanyi, Martin Schostak, Eyck von der Heyde, Wolfgang Schultze-Seemann, Hanjo Belz, Martin Bögemann, Meng Wang, Martin Herber, Jens Bedke
Publikováno v:
European urology focus. 8(5)
Background: Nivolumab monotherapy is approved for the treatment of advanced renal cell carcinoma (aRCC) after prior therapy on the basis of results from CheckMate 025. Objective: The NORA (NivOlumab in Renal cell cArcinoma) noninterventional study (N
Publikováno v:
Experimental Hematology. 37:998-1006
Objective Donor lymphocyte transfusions (DLT) are effective in the treatment of leukemia after allogeneic stem cell transplantation. Graft-vs-host-disease (GVHD) is the major risk factor of DLT. In dog leukocyte antigen (DLA)−identical littermate d
Autor:
Maike Scholtes, Lukas Westhofen, Lara Ruth Turner, Katrin Lotto, Michael Schuldes, Hendrik Weber, Nicolas Wagener, Christian Neurohr, Martin Herbert Bollmann, Franziska Kortke, Johannes Hiller, Michael Hoss, Julian Bock, Lutz Eckstein
Publikováno v:
IEEE Access, Vol 9, Pp 59131-59147 (2021)
Verification and validation of automated driving functions impose large challenges. Currently, scenario-based approaches are investigated in research and industry, aiming at a reduction of testing efforts by specifying safety relevant scenarios. To d
Externí odkaz:
https://doaj.org/article/e80a615f2ff44355bff3228d1833abd4
Autor:
Christian Neurohr, Lukas Westhofen, Martin Butz, Martin Herbert Bollmann, Ulrich Eberle, Roland Galbas
Publikováno v:
IEEE Access, Vol 9, Pp 18016-18041 (2021)
The process of verification and validation of automated vehicles poses a multi-faceted challenge with far-reaching societal, economical and ethical consequences. In particular, fully automated vehicles at SAE Level 4 and 5 will be expected to operate
Externí odkaz:
https://doaj.org/article/d59880cd834d4f5d88b9f0390d26e74c
Publikováno v:
Blood. 110:2173-2173
Adoptive immunotherapy with donor lymphocyte infusion (DLI) following bone marrow transplantation may produce a graft-versus-leukemia (GVL) effect after transplantation of T-cell-depleted bone marrow. However, this method is limited by a high risk of
Autor:
Sebastian Brenner, Fernando Ugarte, Marcus Gentsch, Sebastian Thieme, Martin F. Ryser, Martin Herber
Publikováno v:
Blood. 108:2574-2574
mRNA transfection is a safe alternative to DNA transfection for transient transgene overexpression in mammalian cells as genomic integration of the transferred nucleic acid is impossible. We developed a new mRNA electroporation protocol for transfect